Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

552 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein.
Li Y, Bhuiyan M, Sarkar FH. Li Y, et al. Among authors: sarkar fh. Int J Oncol. 1999 Sep;15(3):525-33. doi: 10.3892/ijo.15.3.525. Int J Oncol. 1999. PMID: 10427135
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.
Merati K, said Siadaty M, Andea A, Sarkar F, Ben-Josef E, Mohammad R, Philip P, Shields AF, Vaitkevicius V, Grignon DJ, Adsay NV. Merati K, et al. Among authors: sarkar f. Am J Clin Oncol. 2001 Oct;24(5):447-52. doi: 10.1097/00000421-200110000-00007. Am J Clin Oncol. 2001. PMID: 11586094
Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.
Visscher DW, Sarkar F, Tabaczka P, Crissman J. Visscher DW, et al. Among authors: sarkar f. Mod Pathol. 1996 Jun;9(6):642-6. Mod Pathol. 1996. PMID: 8782201
p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: a molecular and immunohistochemical analysis.
Rakozy C, Grignon DJ, Li Y, Gheiler E, Gururajanna B, Pontes JE, Sakr W, Wood DP Jr, Sarkar FH. Rakozy C, et al. Among authors: sarkar fh. Pathol Res Pract. 1999;195(3):129-35. doi: 10.1016/S0344-0338(99)80024-7. Pathol Res Pract. 1999. PMID: 10220791
Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma.
Li Y, Bhuiyan M, Vaitkevicius VK, Sarkar FH. Li Y, et al. Among authors: sarkar fh. Pancreas. 1999 Jan;18(1):104-10. doi: 10.1097/00006676-199901000-00013. Pancreas. 1999. PMID: 9888666
Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
Dergham ST, Dugan MC, Arlauskas P, Du W, Vaitkevicius VK, Crissman JD, Sarkar FH. Dergham ST, et al. Among authors: sarkar fh. Int J Pancreatol. 1997 Jun;21(3):225-34. doi: 10.1007/BF02821608. Int J Pancreatol. 1997. PMID: 9322121
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
Dergham ST, Dugan MC, Kucway R, Du W, Kamarauskiene DS, Vaitkevicius VK, Crissman JD, Sarkar FH. Dergham ST, et al. Among authors: sarkar fh. Int J Pancreatol. 1997 Apr;21(2):127-43. doi: 10.1007/BF02822384. Int J Pancreatol. 1997. PMID: 9209954
Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx.
Sarkar FH, Sakr WA, Li YW, Jacobs J, Crissman JD. Sarkar FH, et al. Diagn Mol Pathol. 1996 Sep;5(3):201-5. doi: 10.1097/00019606-199609000-00009. Diagn Mol Pathol. 1996. PMID: 8866234
Molecular cloning and sequencing of an intron of Her-2/neu (ERBB2) gene.
Sarkar FH, Ball DE, Li YW, Crissman JD. Sarkar FH, et al. DNA Cell Biol. 1993 Sep;12(7):611-5. doi: 10.1089/dna.1993.12.611. DNA Cell Biol. 1993. PMID: 8104414
Concurrent abnormal expression of ERBB-2, EGFR, and p53 genes and clinical disease progression of breast carcinoma.
Visscher DW, Castellani R, Wykes SM, Sarkar FH, Hussain ME. Visscher DW, et al. Among authors: sarkar fh. Breast Cancer Res Treat. 1993 Dec;28(3):261-6. doi: 10.1007/BF00666587. Breast Cancer Res Treat. 1993. PMID: 7912562
552 results
Jump to page
Feedback